Prenetics Global Limited Warrants(17/05/2027) PRENW 深 滬
等待開盤 12-17 09:30:00 美东时间
0.0231
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0231
- 總市值 0
- 52周最高 0.0695
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.0067
- 委 比 93.79%
- 總股本 --
- 歷史最高 0.636
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Prenetics Announces Upcoming Conference Participation
Prenetics Global Limited (NASDAQ: PRE) announced its participation in two upcoming investor conferences: The Benchmark Company’s 14th Annual Discovery One-on-One Conference on December 4, 2025, in New York City, and Sidoti’s Year End Virtual Investor Conference on December 10-11, 2025. CEO Danny Yeung and CFO Stephen Lo will attend, with Yeung delivering a presentation at Sidoti’s event. The presentation will be available for viewing at the provi...
11-25 13:49
Prenetics executives buy $1.45M in company stock
Prenetics (PRE) executives collectively purchased 111,911 shares for about $1.45M during the company’s trading window. Chief executive officer Danny Yeung bought 40,118 shares for roughly $502,000 at ...
11-24 20:42
Prenetics Global's Executives Acquire ~$1.4M Common Shares
Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today
11-24 20:33
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million
Prenetics Global Limited's executive leadership team purchased a total of 111,911 shares of the company's common stock during the designated trading window, amounting to approximately $1,446,887. CEO Danny Yeung emphasized the team's conviction in Prenetics' long-term vision, highlighting IM8's rapid growth and the company's Bitcoin-treasury strategy. As a leader in health-tech and longevity, Prenetics is paving the way for future growth through ...
11-24 12:30
Prenetics CEO Increases Stake with Significant Share Purchase
An update from Prenetics Group ( ($PRE) ) is now available. On November 19, 202...
11-20 21:23
Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth
Prenetics Global Limited (PRE) announces that Cantor Fitzgerald has maintained its Overweight rating, adjusting the 12-month price target to $31 due to model updates related to the divestment of its Europa business. Cantor highlights Prenetics' strong operating performance, including 3Q25 revenue of $23.6 million (568% YoY growth), IM8 revenue of $17.2 million (76% sequential growth with 60% gross margins), a 3.9-month customer payback period, an...
11-14 13:35
Prenetics Global Affirms FY2025 Sales Guidance of $90.000M-$100.000M vs $186.700M Est
Prenetics Global (NASDAQ:PRE) affirms FY2025 sales outlook from $90.000 million-$100.000 million to $90.000 million-$100.000 million vs $186.700 million estimate.
11-10 20:48
Prenetics Global Q3 EPS $(0.41) Beats $(0.65) Estimate, Sales $23.555M Miss $25.200M Estimate
Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.65) by 36.92 percent. This is a 47.44 percent increase over losses of $(0.78) per share from
11-10 20:33
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Prenetics Global's Earnings: A Preview
Prenetics Global (NASDAQ:PRE) is preparing to release its quarterly earnings on...
11-08 04:05
